Published in Arch Biochem Biophys on July 01, 1991
Partial purification and properties of an inducible uridine 5'-diphosphate-glucose-salicylic Acid glucosyltransferase from oat roots. Plant Physiol (1992) 1.04
Biosynthesis of p-Hydroxybenzoate from p-Coumarate and p-Coumaroyl-Coenzyme A in Cell-Free Extracts of Lithospermum erythrorhizon Cell Cultures. Plant Physiol (1994) 0.86
Roots of clinical resistance to STI-571 cancer therapy. Science (2001) 9.78
A world without mangroves? Science (2007) 6.13
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Leukemia (2002) 3.90
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res (2001) 2.06
Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia (1999) 1.55
Intramedullary pressure and bone marrow fat extravasation in reamed and unreamed femoral nailing. J Orthop Res (1999) 1.53
The ABBA family of aromatic prenyltransferases: broadening natural product diversity. Cell Mol Life Sci (2008) 1.50
Biocomplexity in mangrove ecosystems. Ann Rev Mar Sci (2010) 1.48
Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates. Lancet (1987) 1.46
Identification of the novobiocin biosynthetic gene cluster of Streptomyces spheroides NCIB 11891. Antimicrob Agents Chemother (2000) 1.40
Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy. J Clin Oncol (1986) 1.39
Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission. Leukemia (2003) 1.37
Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J (Clin Res Ed) (1987) 1.36
Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet (1989) 1.36
Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha. Leukemia (2002) 1.31
Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study. Lancet (1999) 1.28
Characterization of polyprenyldiphosphate: 4-hydroxybenzoate polyprenyltransferase from Escherichia coli. Biochim Biophys Acta (1994) 1.28
Growth factor expression in normal, benign, and malignant breast tissue. Br Med J (Clin Res Ed) (1988) 1.24
Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur J Cancer (1991) 1.23
Identification of the coumermycin A(1) biosynthetic gene cluster of Streptomyces rishiriensis DSM 40489. Antimicrob Agents Chemother (2000) 1.22
[Menigitis due to Moraxella osloensis (author's transl)]. Infection (1974) 1.21
Fine structure and taxonomic position of Neisseria haemolysans (Thjotta and Boe 1938) or Gemella haemolysans (Berger 1960). Acta Pathol Microbiol Scand B Microbiol Immunol (1970) 1.20
Rates and odds ratios for complications in closed and open tibial fractures treated with unreamed, small diameter tibial nails: a multicenter analysis of 467 cases. J Orthop Trauma (2001) 1.18
ATP-dependent transport of taurocholate across the hepatocyte canalicular membrane mediated by a 110-kDa glycoprotein binding ATP and bile salt. J Biol Chem (1991) 1.18
Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer. Gynecol Oncol (2001) 1.16
[Some properties of carrier strains of Listeria monocytogenes (author's transl)]. Med Microbiol Immunol (1975) 1.15
Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg (2004) 1.15
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C. Leukemia (2003) 1.11
Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy. Clin Cancer Res (2001) 1.10
Differentiation of Gemella haemolysans (Thjøtta and Bøe 1938) Berger 1960, from Streptococcus morbillorum (Prevot 1933) Holdeman and Moore 1974. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 1.09
Cloning, overexpression, and purification of novobiocic acid synthetase from Streptomyces spheroides NCIMB 11891. J Biol Chem (2000) 1.06
Ubiquinone biosynthesis. Cloning of the genes coding for chorismate pyruvate-lyase and 4-hydroxybenzoate octaprenyl transferase from Escherichia coli. FEBS Lett (1992) 1.06
[Acetazolamide-resistance as a taxonomic criterion of Neisseria]. Arch Hyg Bakteriol (1971) 1.05
Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc. Br J Cancer (1999) 1.05
Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle. Br Med J (Clin Res Ed) (1988) 1.04
Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse. Breast Cancer Res Treat (1999) 1.03
Partial purification and properties of geranyl pyrophosphate synthase from Lithospermum erythrorhizon cell cultures. Arch Biochem Biophys (1989) 1.03
Prevalence of Gemella haemolysans on the pharyngeal mucosa of man. Med Microbiol Immunol (1985) 1.02
Detection and quantification of residual disease in chronic myelogenous leukemia. Leukemia (2000) 1.02
Geographic and temporal variations in pollen exposure across Europe. Allergy (2014) 1.01
Formation of 4-hydroxybenzoate in Escherichia coli: characterization of the ubiC gene and its encoded enzyme chorismate pyruvate-lyase. Microbiology (1994) 1.00
Presurgical determination of estrogen receptor status using immunocytochemically stained fine needle aspirate smears in patients with breast cancer. Cancer Res (1987) 0.99
Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up. Br J Cancer (1999) 0.98
Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques. J Urol (1988) 0.98
A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia. Blood (1996) 0.96
Historical trends in persistent organic pollutants and metals recorded in sediment from Lake Ellasjøen, Bjørnøya, Norwegian Arctic. Environ Pollut (2006) 0.96
Genetic engineering of shikonin biosynthesis hairy root cultures of Lithospermum erythrorhizon transformed with the bacterial ubiC gene. Plant Mol Biol (1999) 0.96
The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol (1989) 0.95
Identification of common allergenic structures in mugwort and ragweed pollen. J Allergy Clin Immunol (1998) 0.95
Effects of H1-receptor antagonists on nasal obstruction in atopic patients. Allergy (1993) 0.95
Distribution of serotypes of Neisseria meningitidis in the Federal Republic of Germany, 1979-1981. Med Microbiol Immunol (1982) 0.94
[Increasing regional disparities in living conditions in Germany and their role in the explanation of health inequalities]. Gesundheitswesen (2009) 0.93
Airborne olive pollen counts are not representative of exposure to the major olive allergen Ole e 1. Allergy (2013) 0.93
Intramedullary pressure and bone marrow fat intravasation in unreamed femoral nailing. J Trauma (1997) 0.92
[Self-assessment of BMI data : verification of the practicability of a correction formula on a sample of 11- to 13-year-old girls]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2011) 0.91
[Distribution of species of Moraxella and moraxella-like organisms in the nasopharynx of healthy human adults (author's transl]. Med Microbiol Immunol (1976) 0.90
Interferon alpha in the treatment of polycythemia vera. Ann Hematol (2000) 0.90
Genetic engineering of plant secondary metabolism. Accumulation of 4-hydroxybenzoate glucosides as a result of the expression of the bacterial ubiC gene in tobacco. Plant Physiol (1996) 0.90
Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha. Leukemia (2005) 0.89
Immunocytochemical assay for estrogen receptor: relationship to outcome of therapy in patients with advanced breast cancer. Cancer Res (1986) 0.89
[Reduction of nitrate and nitrite by Neisseria gonorrhoeae and Neisseria meningitidis]. Z Med Mikrobiol Immunol (1970) 0.88
Tissue expansion in pig skin--a histochemical approach. Anat Histol Embryol (1992) 0.88
Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double blind clinical trial. Phytother Res (2001) 0.87
First isolation of Neisseria polysacchareae species nova in the Federal Republic of Germany. Eur J Clin Microbiol (1985) 0.87
Metabolism and actions of 2-deoxy-2-fluoro-D-galactose in vivo. Eur J Biochem (1990) 0.87
[Neisseria mucosa var. heidelbergensis]. Z Med Mikrobiol Immunol (1971) 0.87
Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer. Int J Biol Markers (2000) 0.87
Headache cessation by an educational intervention in grammar schools: a cluster randomized trial. Eur J Neurol (2014) 0.86
Acute action of DSP-4 on central norepinephrine axons: biochemical and immunohistochemical evidence for differential effects. J Histochem Cytochem (1989) 0.86
4-Hydroxybenzoate 3-geranyltransferase from Lithospermum erythrorhizon: purification of a plant membrane-bound prenyltransferase. Planta (1998) 0.86
Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate. Leukemia (2003) 0.85
[Endocarditis lenta caused by Lactobacillus salivarius subsp. salicinicus (author's transl)]. Dtsch Med Wochenschr (1976) 0.84
Brominated flame retardants and other organobromines in Norwegian predatory bird eggs. Chemosphere (2005) 0.84
cDNA cloning and gene expression of phenylalanine ammonia-lyase in Lithospermum erythrorhizon. Biosci Biotechnol Biochem (1997) 0.84
Clinical relevance of T1-S, an oncogene-inducible, secreted glycoprotein of the immunoglobulin superfamily, in node-negative breast cancer. Lab Invest (2001) 0.84
Immunohistochemistry of porcine skin. Acta Histochem (1991) 0.84
ABL-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia. Blood (2001) 0.83
Quantification of conjunctival vascular reaction by digital imaging. J Allergy Clin Immunol (1996) 0.83
Genetic engineering on shikonin biosynthesis: expression of the bacterial ubiA gene in Lithospermum erythrorhizon. Plant Cell Physiol (2000) 0.82
Enzymatic synthesis of the coenzyme A ester of o-succinylbenzoic acid, an intermediate in menaquinone (vitamin K2) biosynthesis. FEBS Lett (1981) 0.82
Regulatory role of microsomal 3-hydroxy-3-methylglutaryl-coenzyme A reductase for shikonin biosynthesis in Lithospermum erythrorhizon cell suspension cultures. Planta (1998) 0.82
Expression of bacterial chorismate pyruvate-lyase in tobacco: evidence for the presence of chorismate in the plant cytosol. Plant Cell Physiol (1998) 0.82
Complications in laparoscopic myomectomy. Surg Endosc (2006) 0.82
The German competence network 'Acute and chronic leukemias'. Leukemia (2004) 0.81
Current trends in the management of chronic myelogenous leukemia. Ann Hematol (2000) 0.81
[Chemotherapeutics sensitivity of meningococci: therapeutic and prophylactic aspects]. Dtsch Med Wochenschr (1973) 0.80
Genetic analysis of the biosynthesis of the pyrrole and carbamoyl moieties of coumermycin A1 and novobiocin. Mol Genet Genomics (2002) 0.80
AraC-based pharmacotherapy of chronic myeloid leukaemia. Expert Opin Pharmacother (2001) 0.79
Geranylhydroquinone 3"-hydroxylase, a cytochrome P-450 monooxygenase from Lithospermum erythrorhizon cell suspension cultures. Planta (2000) 0.79
Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients. Allergy (1998) 0.79
The uptake of lithium ions by synthetic carbonated hydroxyapatite. Calcif Tissue Int (1986) 0.79
Mastitis severity induced by two Streptococcus uberis strains is reflected by the mammary immune response in vitro. Schweiz Arch Tierheilkd (2012) 0.79
Pharmacokinetics of salicin after oral administration of a standardised willow bark extract. Eur J Clin Pharmacol (2001) 0.79
New aminocoumarin antibiotics from genetically engineered Streptomyces strains. Curr Med Chem (2005) 0.79